Dr. Rajatha Maradi Hemanth Kumar Honoured with Bharat Shreshtha Ratna Sanman 2026 for Advancing AI-Driven Precision Oncology
New Delhi [India], July 20: In recognition of his pioneering contributions to clinical medicine, artificial intelligence, and cancer research, Dr. Rajatha Maradi Hemanth Kumar has been honoured with the Bharat...
New Delhi [India], July 20: In recognition of his pioneering contributions to clinical medicine, artificial intelligence, and cancer research, Dr. Rajatha Maradi Hemanth Kumar has been honoured with the Bharat Shreshtha Ratna Sanman 2026. The prestigious recognition celebrates professionals whose work is creating meaningful impact in their respective fields, and for Dr. Rajatha, it acknowledges years of dedication to advancing precision medicine through research, innovation, and compassionate patient care. A physician-scientist based in Bengaluru, Dr. Rajatha has steadily built a reputation for combining frontline clinical practice with cutting-edge research. While many medical professionals focus exclusively on patient care or academia, he has successfully bridged both worlds by translating scientific discoveries into practical healthcare solutions. His work centres on one of the fastest-growing areas in modern medicine: AI-driven precision oncology. Through extensive research, he has explored how artificial intelligence, digital twins, predictive analytics, and multi-modal clinical data can improve early cancer detection, treatment planning, and patient outcomes. His vision is to make healthcare more personalised, accurate, and evidence-based.
Alongside his research, Dr. Rajatha continues to serve patients in high-volume clinical settings, treating thousands of individuals annually. His medical career spans preventive healthcare, chronic disease management, maternal health, paediatrics, emergency medicine, and public health. During the COVID-19 pandemic, he also contributed significantly to India’s vaccination drive, administering more than 150,000 vaccine doses while serving as a frontline medical officer. His scientific achievements have attracted national and international recognition. As the sole author of multiple Scopus-indexed research papers and five scientific books, he has contributed extensively to the fields of oncology, immunotherapy, nanomedicine, and genomic therapeutics. His research has earned citations from fellow scientists while also supporting future developments in predictive healthcare. Innovation remains another defining aspect of his journey. Dr. Rajatha has developed multiple Indian patents focused on AI-powered oncology systems and has also filed a United States utility patent related to predictive oncology and bio-digital twin intelligence. These innovations reflect his long-term vision of integrating technology into clinical decision-making to improve patient care.
